Shanghai Model Organisms Center, Inc. (SHA:688265)
China
· Delayed Price · Currency is CNY 41.39
-0.03 (-0.07%)
Apr 30, 2026, 11:03 AM CST
SHA:688265 Revenue
In the year 2025, Shanghai Model Organisms Center had annual revenue of 421.02M CNY with 10.44% growth. Shanghai Model Organisms Center had revenue of 118.32M in the quarter ending December 31, 2025, with 1.66% growth.
Revenue
421.02M
Revenue Growth
+10.44%
P/S Ratio
7.44
Revenue / Employee
575.96K
Employees
749
Market Cap
3.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 421.02M | 39.78M | 10.44% |
| Dec 31, 2024 | 381.24M | 14.69M | 4.01% |
| Dec 31, 2023 | 366.55M | 63.58M | 20.99% |
| Dec 31, 2022 | 302.97M | 27.70M | 10.06% |
| Dec 31, 2021 | 275.27M | 79.08M | 40.31% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Bioeasy Biotechnology | 263.23M |
| Jiangsu Sihuan Bioengineering | 344.38M |
| Landfar Bio-medicine | 125.47M |
| Guangdong VTR Bio-Tech | 832.26M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Novoprotein Scientific | 151.51M |
| Beijing Kawin Technology Share-Holding | 1.30B |
| Shanghai Shen Lian Biomedical | 288.27M |